Heyholder
‹ Back to the disclosure you were reading

Dong-A Pharmaceutical Co.,Ltd. New executive Kwon Soon-hwan reports holding 26 shares

Dong-A Pharmaceutical Co.,Ltd.· Insider Ownership

AI summary · Not investment advice

Newly appointed executive Kwon Soon-hwan reported holding 26 common shares, a 0.00% stake.

Key facts

Relationship with issuer
Unregistered executive, Managing Director (Sangmu)
Date of change
Nov 1, 2026

Commentary

AI commentary · Not investment advice

What happened

Dong-A Pharmaceutical's executive Kwon Soon-hwan filed a first-time report saying he holds 26 shares of the company.

In the company's terms

This is a new report, which is filed when a person newly becomes an executive. He is an unregistered executive (an officer not on the board of directors) with the title of managing director. The shares he holds are common shares.

What changes for shareholders

The filing lists his ownership ratio as 0.00% of the company's issued shares. The materials give no later schedule or plans for further trades.

Earlier Insider Ownership filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.06Insider Ownership67 shares · Common shares held following new appointment
26.11.06Insider Ownership30 shares
26.11.06Insider Ownership220 shares · Common shares held after change due to new appointment

Comments

No comments yet

Comments from shareholders will appear here.